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General information and experimental procedure
1) General information:
All reactions were performed in air atmosphere unless otherwise stated. The commercially available reagents were used as supplied without further purification.
Chloroform and THF were dried according to procedures described in the literatures, and other solvents were used as received without further purification unless otherwise stated. Column chromatography was performed with silica gel (200 -300 mesh) produced by Qingdao Marine Chemical Factory, Qingdao (China). All yields were given as isolated yields. NMR spectra were recorded on a Bruker DPX 300 MHz spectrometer (or Bruker DPX 400 MHz spectrometer) with internal standard tetramethylsilane (TMS) and solvent signals as internal references at 298 K, and the chemical shifts (δ) were expressed in ppm and J values were given in Hz. Lowresolution electrospray ionization mass spectra (LR-ESI-MS) were obtained on Finnigan Mat TSQ 7000 instruments. High-resolution electrospray ionization mass spectra (HR-ESI-MS) were recorded on an Agilent 6540Q-TOF LCMS equipped with an electrospray ionization (ESI) probe operating in positive-ion mode with direct infusion. Dynamic light scattering (DLS) measurements were carried out on a Brookhaven BI-9000AT system (Brookhaven Instruments Corporation, USA), using a 200-mW polarized laser source (λ = 514 nm). Zeta-potential measurements were performed at 25 °C on a Zetasizer Nano Z apparatus (Malvern Instruments Ltd., UK) using the Smoluchowski model for the calculation of the Zeta-potential from the measured electrophoretic mobility. The UV-Vis absorption spectra were measured on a Perkin Elmer Lambda 35 UV-Vis Spectrometer. Transmission electron microscope (TEM) investigations were carried out on a JEM-2100 instrument.
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2) Experimental procedure:
Fabrication of GalP5G supramolecular prodrug nanoparticles. GalP5G nanoparticles were prepared as follows: CPT-prodrug G (3.0 mg) was dissolved in water (45 mL, 1 % DMSO was added to improve the solubility of G), then an aqueous solution of GalP5 (5 mL, C = 0.8 mM) was injected. The ultimate concentrations of G and GalP5 were both 0.08 mM. After standing overnight, the prepared GalP5G nanoparticles were purified by dialysis (molecular weight cutoff 10 000) in distilled water for several times until the water outside the dialysis tube exhibited negligible CPT absorption.
The CPT encapsulation efficiency and loading content were calculated by the where m CPT-loaded , m CPT , and m GalP5 are mass of CPT encapsulated into the nanoparticles, mass of CPT-prodrug G and GalP5 added, respectively. The mass of CPT was measured by a UV spectrophotometer at 365 nm and calculated as relative to a standard calibration curve in the concentrations from 2 to 80 μM.
GSH-responsive behaviors of the supramolecular prodrug nanoparticles. In a typical GSH-induced release experiment, a certain amount of GSH solution was added into 10 mL of the GalP5G nanoparticle solution, the final GSH concentration was 2 mM, 5 mM, and 10 mM, respectively. At selected time intervals, 2 mL of the release media was taken out for measuring the released CPT concentrations by UVVis absorbance technique, and then was returned to the original release media. A nearly 100% release of CPT from GalP5G nanoparticles was obtained by adding Triton X-100 to the nanoparticle solution.
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In vitro cell cytotoxicity assay. Then, the culture medium was removed and cells were washed with PBS thrice.
Thereafter, the LysoTracker Red DND-99 (Thermo Fisher, USA) was added to the medium with a final concentration of 50 nM and incubated for 1 h to label lysosomes.
Finally, after removing the culture medium and washing with PBS thrice, the cells were fixed with 4% paraformaldehyde and investigated by fluorescence microscopy (LSM710, CarlZeiss). The fluorescence characteristics of GalP5G prodrug nanoparticles were used to directly monitor the localization of CPT without utilizing additional dye.
Statistical analysis. Differences between treatment groups were statistically analyzed using the paired Student's test. A statistically significant difference was reported if p < 0.05 or less. The data were expressed as mean ± standard deviation from at least three separate experiments.
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Synthesis of host GalP5
The synthetic procedures for host GalP5 was shown in Scheme S1.
Scheme S1. Synthetic route for host GalP5.
Synthesis of compound 1
S1
Compound 1 was prepared according to previously reported method. 
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Synthesis of compound 2
S2
Compound 2 was prepared according to previously reported method. 169. 6, 149.7, 144.3, 128.6, 124.0, 115.6, 101.0, 77.3, 77.1, 76.7, 70.7, 68.5, 67.7, 67.0, 62.4, 61.1, 50.0, 20.9, 20 .5. Figure S3 .
1 H NMR spectrum (400 MHz, CDCl 3 , 298 K) of compound 3. Figure S4 . 13 C NMR spectrum (100 MHz, CDCl 3 , 298 K) of compound 3. 
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Synthesis of host GalP5
Synthesis of CPT prodrug guest G
The synthetic procedures for CPT prodrug guest G was shown in Scheme S2.
Scheme S2. Synthetic route for CPT prodrug guest G.
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Synthesis of compound 4
S3
Compound 4 was prepared according to previously reported method S3 with some modifications.
Bis(2-hydroxyethyl) disulfide (7.7 g, 50.0 mmol) and propargyl bromide (3.0 g, 25.0 mmol) were dissolved in THF (200 mL). Then, NaH powder (80 wt %, 1.5 g, 37.5 mmol) was added into the reaction mixture in three successive batches under nitrogen atmosphere within 2 h at 0 °C. The mixture was further stirred for another 8 h at room temperature, and then a few drops of water were added to quench the reaction. The mixture was filtered, and the solvent was removed by evaporation. The 167. 3, 157.3, 153.5, 152.3, 148.9, 146.5, 145.6, 132.1, 131.3, 130.8, 129.7, 128.5, 128.2, 128.1, 120.3, 96.1, 78.0, 74.9, 67.9, 67.1, 66.7, 58.2, 50.0, 38.6, 36.5, 31.9, 29.7, 7.7 Figure S15. HR-ESI-MS spectrum of compound 7. 128.3, 124.2, 119.7, 94.9, 78.4, 68.1, 66.9, 66.7, 65.6, 63.7, 55.4, 52.6, 51.0, 49.6, 38.3, 36.7, 29.8, 28.4, 26.1, 25.8, 22.4, 8. 
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Synthesis of compound G
Zeta-potentials of the aggregates formed by GalP5G
Figure S24. Zeta-potential of the aggregates formed by GalP5⊃G. Figure S25 . TEM images of GalP5G aggregates in the presence of GSH (10.0 mM). Table S1 . Cytotoxicity of GalP5G prodrug nanoparticles agains HepG2 and HeLa cells at different concentrations after 24 h incubation.
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TEM images of GalP5G aggregates under GSH-stimulus
DLS data of GalP5G aggregates in PBS and
In vitro cell assay
